Authors: Smith, RA Barbosa, J Blum, CL Bobko, MA Caringal, YV Dally, R Johnson, JS Katz, ME Kennure, N Kingery-Wood, J Lee, W Lowinger, TB Lyons, J Marsh, V Rogers, DH Swartz, S Walling, T Wild, H

Citation: Ra. Smith et al., Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: Identification of a second generation lead by a combinatorial chemistry approach, BIOORG MED, 11(20), 2001, pp. 2775-2778

Authors: Redman, AM Johnson, JS Dally, R Swartz, S Wild, H Paulsen, H Caringal, Y Gunn, D Renick, J Osterhout, M Kingery-Wood, J Smith, RA Lee, W Dumas, J Wilhelm, SM Housley, TJ Bhargava, A Ranges, GE Shrikhande, A Young, D Bombara, M Scott, WJ

Citation: Am. Redman et al., p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: Thienyl, furyl, and pyrrolyl ureas, BIOORG MED, 11(1), 2001, pp. 9-12

Authors: Spencer-Smith, J Wild, H Innes-Ker, AH Townsend, J Duffy, C Edwards, C Ervin, K Merritt, N Paik, JW

Citation: J. Spencer-smith et al., Making faces: Creating three-dimensional parameterized models of facial expression, BEHAV RE ME, 33(2), 2001, pp. 115-123

Authors: Matassova, NB Rodnina, MV Endermann, R Kroll, HP Pleiss, U Wild, H Wintermeyer, W

Citation: Nb. Matassova et al., Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors, RNA, 5(7), 1999, pp. 939-946